SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron

SARS-CoV-2 Seroprevalence among Canadian Blood Donors: The Advance of Omicron

With the emergence of the SARS-CoV-2 Omicron variant in late 2021, Canadian public health case/contact testing was scaled back due to high infection rates with milder symptoms in a highly vaccinated population. We monitored the seroprevalence of SARS-CoV-2 nucleocapsid (anti-N) and spike protein (an...

Full description

Bibliographic Details
Main Authors: Sheila F. O’Brien, Niamh Caffrey, Qi-Long Yi, Chantale Pambrun, Steven J. Drews
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Viruses
Subjects:
SARS-CoV-2
seroprevalence
Canada
blood donors
Omicron
Online Access:https://www.mdpi.com/1999-4915/14/11/2336

Internet

https://www.mdpi.com/1999-4915/14/11/2336

Similar Items